Alistair Ring
0000-0003-1230-2973
8 papers found
Refreshing results…
Supplementary Table S5 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
Supplementary Table S4 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
Supplementary Table S3 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1 mutant breast cancer
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial
Improving outcomes for women aged 70 years or above with early breast cancer: research programme including a cluster RCT
Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality
Missing publications? Search for publications with a matching author name.